Anti-inflammatory potential of platinum nanozymes: mechanisms and perspectives

Giuseppe Bardi1, Luca Boselli1, Pier Paolo Pompa1

  • 1Nanobiointeractions & Nanodiagnostics, Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy. giuseppe.bardi@iit.it.

Nanoscale
|August 16, 2023
PubMed

Insights

Platinum nanozymes (PtNZs) offer a novel therapeutic strategy by scavenging reactive oxygen species (ROS) to reduce inflammation. Engineering PtNZs can enhance their anti-inflammatory effects and target specific inflammatory pathways.

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Immunology

Background:

  • Inflammation is a critical biological response to stimuli but can cause tissue injury if uncontrolled.
  • Reactive Oxygen Species (ROS) are key mediators in inflammation, necessitating their regulation for therapeutic benefit.
  • Current anti-inflammatory drugs primarily inhibit pro-inflammatory mediator release, highlighting the need for alternative approaches like ROS scavenging.

Purpose of the Study:

  • To review the role of platinum-based nanozymes (PtNZs) in modulating inflammation.
  • To explore PtNZs' potential as an alternative or complementary therapeutic strategy for inflammation.
  • To discuss the design and engineering of PtNZs for enhanced anti-inflammatory efficacy.

Main Methods:

  • Review of existing literature on inflammation, ROS, and nanozymes.
  • Analysis of platinum nanozyme catalytic activities, particularly ROS scavenging (catalase and superoxide dismutase mimicry).
  • Evaluation of in vitro and in vivo biocompatibility and immune compatibility data for PtNZs.

Main Results:

  • Platinum nanozymes (PtNZs) effectively reduce inflammation by scavenging ROS.
  • PtNZs demonstrate dose-dependent biocompatibility and immune compatibility.
  • Engineering PtNZs (size, shape, surface) can improve their targeting and efficacy in inflammatory processes.

Conclusions:

  • Platinum nanozymes represent a promising therapeutic avenue for managing inflammation through ROS regulation.
  • Further design and engineering of PtNZs can optimize their anti-inflammatory actions and expand their therapeutic applications.
  • PtNZs offer a stable and regenerable catalytic approach to combatting inflammation.

Related Concept Videos